Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
23
days
Clonal Hematopoiesis in Newly Diagnosed Multiple Myeloma: Associations With Neutropenia, Supportive Care Burden, and Survival
AuthorsAhmet Yigitbasi; Fulya Oz Puyan; Hakki Onur Kirkizlar; Tugcan Alp Kirkizlar; Nuray Can; Ebru Tastekin; Seyma Keles Karahan; Elif Gulsum Umit; Ahmet Muzaffer Demir
AffiliationsDepartment of Hematology, Faculty of Medicine, Trakya University, Edirne, Türkiye; Department of Pathology, Faculty of Medicine, Trakya University, Edirne, Türkiye; Department of Internal Medicine, Faculty of Medicine, Trakya University, Edirne, Türkiye
21
days
Pre-CAR-HEMATOTOX at Leukapheresis Predicts Delayed Platelet Recovery After Idecabtagene Vicleucel in Multiple Myeloma
AuthorsTaku Kikuchi; Moe Nomura-Yogo; Ukyo Kondo; Shotaro Sugita; Miyu Watanabe; Chiaki Matsumoto; Kodai Kunisada; Kota Sato; Tomomi Takei; Yu Abe; Osamu Hosoya; Tadao Ishida; Nobuhiro Tsukada
AffiliationsDepartment of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan; Department of Pharmacy, Japanese Red Cross Medical Center, Tokyo, Japan
16
days
Malignancy-Associated Hemophagocytic Lymphohistiocytosis: Clinical Characteristics, Treatment Patterns, and Survival Outcomes in a Tertiary Care Center Cohort
AuthorsRicardo Kosch; Winfried Alsdorf; Paymon Ahmadi; Angelique Hölzemer; Aiman Gamal Abdelrahim; Kyra Ahrens; Carsten Bokemeyer; Katja Weisel; Piet Sonnemann; Maximilian Al-Bazaz
AffiliationsDepartment of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Institute for Infection Research and Vaccine Development (IIRVD), Center for Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Knowledge Technology Group, Department of Informatics, University of Hamburg, Hamburg, Germany
99
days
Treatment in Clinical Trials Could Mitigate Socioeconomic and Racial Disparities in Acute Myeloid Leukemia
AuthorsMahesh Swaminathan; Hussein A. Abbas; Michael Roth; Michelle A.T. Hildebrandt; Warren Fingrut; Tapan Kadia; Naval Daver; Courtney DiNardo; Gautam Borthakur; Elias Jabbour; Naveen Pemmaraju; Yesid Alvarado; Maro Ohanian; Nitin Jain; Nicholas Short; Prithviraj Bose; Koichi Takahashi; Sherry Pierce; Hyunsoo Hwang; Xuelin Huang; Paul Edelkamp; Partow Kebriaei; Uday Popat; Elizabeth Shpall; Guillermo Garcia-Manero; Farhad Ravandi
AffiliationsDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Enterprise Data Engineering and Analytics, The University of Texas MD Anderson Cancer Center, Houston, TX
49
days
The Influence of Racial, Socioeconomic, and Geographic Disparities in the Survival of Patients With Plasmablastic Lymphoma: A Population-Based Analysis From the Surveillance, Epidemiology, and End Results (SEER) Database (2000-2022)
AuthorsShahzaib Maqbool; Mohammad Ebad UR Rehman; Muhammad Ibrahim; Syed Imam Naufil; Mouzma Ali; Arham Ihtesham; Muhammad Ibrahim Rashid; Muhammad Osama; Imran Khan; Abat Khan; Jose David Sandoval-Sus; Carlos H. Silva Rondon; Mehdi Hamadani; Amir Kamran; Ahmad Iftikhar; Muhammad Salman Faisal
AffiliationsInternal Medicine, HCA Healthcare/Centerpoint Medical Center, Independence, MO, 64057, USA; Internal Medicine, NYC Health and Hospitals/Jacboi, NYC, NY, 10461, USA; Internal Medicine, Creighton University, Omaha, NE, 68124, USA; Internal Medicine, Multan Medical and Dental College, Multan, Pubjab, 60000, Pakistan; Internal Medicine, Rawalpindi Medical University, Rawalpindi, Punjab, 46000, Pakistan; Memorial Healthcare system, Pembroke Pines, FL, 33025, USA; Internal Medicine, NYC Health and Hospitals/Woodhull Medical Center, NYC; Memorial Healthcare System, Hematology and Oncology Fellowship Program; Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, 53226, USA; Hematology and Oncology, Charleston Area Medical Center Vandalia Health, Charleston, WV, 25304, USA; Heamtology and Oncology, University of Arizona, Tucson, AZ, 85721, USA; Hematology and Oncology, Oklahoma University Health Sciences Center, OKC, OK, 73019, USA
12
days
Knowledge, Awareness, and Practice Patterns of Nephrologists in the Diagnosis and Management of Multiple Myeloma (MIND-MM Study): A Cross-Sectional, Web-Based, CHERRIES-Compliant Survey with Position Statement from the Indian Myeloma Academic Groupe (IMAGe) and Indian Society of Nephrology (ISN)
AuthorsUday Yanamandra; Raja Ramachandran; Vinay Sakhuja; Ranjith Nair; Vivekanand Jha; Shaji K. Kumar; Nelson Leung; Pankaj Malhotra
AffiliationsArmed Forces Medical College, Pune, Maharashtra, India; Post Graduate Institute of Medical Education and Research, Chandigarh, India; Armed Forces Medical Services, New Delhi, India; George Institute for Global Health, University of New South Wales, New Delhi, India / University of Oxford, Oxford, United Kingdom; Mayo Clinic, Rochester, MN
24
days
Validation of a QuPath-Based Artificial Intelligence Workflow for Plasma Cell Quantification on CD138 Immunohistochemistry in an Indian Hematopathology Cohort
AuthorsMohammed N. Meera; Ankur Ahuja; Venkatesan Somasundaram; Gurpreet Kaur; Parikshit Sanyal; Uday Yanamandra
AffiliationsDepartment of Pathology, Armed Forces Medical College, Pune, India; Department of Pathology, Command Hospital (Eastern Command), Kolkata, India; Department of Medical Research, Armed Forces Medical College, Pune, India
51
days
Association of GLP1-Receptor Agonists With Risk of Hematologic Malignancies in People With Diabetes
AuthorsSamuel Ramos; Shin Zaw; Allison Carilli; Ishak A. Mansi
AffiliationsDepartment of Internal Medicine, University of Central Florida, Greater Orlando, FL; University of Central Florida College of Medicine, HCA Florida Healthcare GME, Greater Orlando, FL; Section of Hematology and Oncology, Orlando VA Healthcare System, Orlando, FL; Education Services, Orlando VA Healthcare System, Orlando, FL
51
days
Real-World Evidence of Immunotherapy Sequencing in Multiple Myeloma: Durable Responses With BCMA-Targeting Bispecific Antibodies Following Prior GPRC5D-Targeting Therapy
AuthorsTitouan Cazaubiel; Cyrille Touzeau; Laure Vincent; Karim Belhadj; Lionel Karlin; Salomon Manier; Aurore Perrot; Marie Christiane Vekemans; Perrine Moyer; Philippe Moreau; Mohamad Mohty; Judith Victor; Cyrille Hulin
AffiliationsDepartment of Hematology, University Hospital of Bordeaux, Pessac, France; Cancer Research Center of Toulouse, INSERM, Toulouse, France; Department of Hematology, University Hospital of Nantes, Nantes, France; Department of Hematology, University Hospital of Montpellier, Montpellier, France; Department of Hematology, Hopital Henri Mondor, Creteil, France; Department of Hematology, University Hospital of Lyon, Hospices Civils de Lyon, Lyon, France; Department of Hematology, University Hospital of Lille, Lille, France; Department of Hematology, University Hospital of Toulouse-Oncopole, Toulouse, France; Department of Hematology, St. Luc Hospital, Brussels, Belgium; Department of Hematology, Sorbonne University, Saint-Antoine Hospital, Paris, France
19
days
Impact of Treatment Sequencing With CAR T-cell Therapies and Bispecific Antibodies on Long-term Survival in 4L+ RRMM in the United States: A Simulation Model
AuthorsJodi Lipof; Brian Bloudek; Avik Ray; Jie Ting; Ken Hasegawa; Cynthia Gong; Troy Williams; Scott Ramsey; Ajai Chari
AffiliationsDivision of Hematology/Oncology, University of California San Francisco, San Francisco, CA; Curta Inc., Seattle, WA; Arcellx Inc., Redwood City, CA; Kite, a Gilead Company, Santa Monica, CA
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days